Dr. Parker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Dr
Mail Code 0987
La Jolla, CA 92093Phone+1 858-249-3248Fax+1 858-249-3250
Summary
- I am a breast medical oncologist and former senior cancer center administrator with over 30 years of experience in clinical care, clinical and translational research, cancer strategic planning and cancer clinical operations.
Education & Training
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1985 - 1987- University of California (San Diego) Medical CenterChief Residency, Internal Medicine, 1984 - 1985
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1981 - 1984
Stanford University School of MedicineClass of 1981
Certifications & Licensure
CA State Medical License 1982 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Docs San Diego 2006-2020
- Lifetime Achievement Award American Cancer Society San Diego, 2019
- Lifetime Achievement Award UCSD Moores Cancer Center, 2018
- Join now to see all
Clinical Trials
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Publications & Presentations
PubMed
- 121 citationsLong-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow...Grant D. Brinkworth, M. Noakes, Barbara A. Parker, Paul R Foster, P.M. Clifton
Diabetologia. 2004-10-06 - 16 citationsWnt5a induces ROR1 to recruit cortactin to promote breast-cancer migration and metastasisKamrul Hasan, George F. Widhopf, Suping Zhang, Sharon M. Lam, Zhouxin Shen
NPJ Breast Cancer. 2019-10-25 - 145 citationsSleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study.Sonia Ancoli-Israel, Lianqi Liu, Michelle Rissling, Loki Natarajan, Ariel B. Neikrug
Supportive Care in Cancer. 2014-04-15
Press Mentions
Researchers to Test Novel Drug Combination Against Toughest Breast CancersAugust 27th, 2018
UCSD Launches New Clinical Trial for Breast Cancer DrugAugust 27th, 2018
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
